05:22 AM EDT, 07/01/2024 (MT Newswires) -- Kiniksa Pharmaceuticals ( KNSA ) on Friday filed a registration statement for the potential offering of up to $400 million worth of securities from time to time.
The filing covers the potential sale of class A ordinary shares, preferred shares, debt securities, warrants and units.